Suppr超能文献

新疆哈萨克族人群总胆红素和间接胆红素含量与代谢综合征的关系。

Association of total bilirubin and indirect bilirubin content with metabolic syndrome among Kazakhs in Xinjiang.

机构信息

Department of Public Health, Shihezi University School of Medicine, Shihezi, 832000, Xinjiang, China.

The First Affiliated Hospital of Shihezi University Medical College, Shihezi, 832000, Xinjiang, China.

出版信息

BMC Endocr Disord. 2020 Jul 22;20(1):110. doi: 10.1186/s12902-020-00563-y.

Abstract

BACKGROUND

Some studies have shown that a high level of bilirubin is a protective factor against metabolic syndrome (MS), while a high level of transaminase is a risk factor for MS. However, the existing results are inconsistent and few cohort studies have been published.

METHODS

Using an ambispective cohort study, 565 Kazakhs from Xinjiang, China were selected as the study subjects. The baseline serum bilirubin and transaminase levels of the subjects were divided into quartiles and the relationship between these values and the incidence of MS was analyzed. The definition of MS was based on the Joint Interim Statement (JIS) diagnostic criteria.

RESULTS

The average follow-up time for the subjects was 5.72 years. The cumulative incidence of MS was 36.11% (204 of the 565 subjects), and the incidence density was 63.10/1000 person-years. Multivariate Cox regression analysis showed that the levels of total bilirubin (TBIL) and indirect bilirubin (IBIL) were negatively correlated with the occurrence of MS, Compared to the lowest quartile level (Q1), the hazard ratios of MS the TBIL levels at the Q2-Q4 quartiles were: 0.47 (0.31-0.71), 0.53 (0.35-0.79), and 0.48 (0.32-0.72), respectively, while IBIL levels at the Q2-Q4 quartiles showed an MS hazard ratio of 0.48 (0.32-0.72), 0.54(0.36-0.81), and 0.52 (0.35-0.77), respectively, all at a 95% confidence level. However, no relationship was found between transaminase levels and the incidence of MS.

CONCLUSION

Serum TBIL and IBIL levels were negatively correlated with the incidence of MS in a Kazakh population in China.

摘要

背景

一些研究表明,胆红素水平较高是代谢综合征(MS)的保护因素,而转氨酶水平较高是 MS 的危险因素。然而,现有的研究结果并不一致,且发表的队列研究较少。

方法

采用前瞻性队列研究,选取中国新疆的 565 名哈萨克族人为研究对象。根据研究对象的基线血清胆红素和转氨酶水平将其分为四分位,并分析这些值与 MS 发病率的关系。MS 的定义基于联合临时声明(JIS)诊断标准。

结果

研究对象的平均随访时间为 5.72 年。MS 的累积发病率为 36.11%(565 例中有 204 例),发病率密度为 63.10/1000人年。多变量 Cox 回归分析表明,总胆红素(TBIL)和间接胆红素(IBIL)水平与 MS 的发生呈负相关。与最低四分位(Q1)相比,TBIL 水平在 Q2-Q4 四分位的 MS 风险比分别为:0.47(0.31-0.71)、0.53(0.35-0.79)和 0.48(0.32-0.72),而 IBIL 水平在 Q2-Q4 四分位的 MS 风险比分别为:0.48(0.32-0.72)、0.54(0.36-0.81)和 0.52(0.35-0.77),均在 95%置信区间内。然而,未发现转氨酶水平与 MS 发病率之间存在关系。

结论

在中国哈萨克族人群中,血清 TBIL 和 IBIL 水平与 MS 的发病率呈负相关。

相似文献

1
3
Correlations between the serum bilirubin level and ulcerative colitis: a case-control study.
Eur J Gastroenterol Hepatol. 2019 Aug;31(8):992-997. doi: 10.1097/MEG.0000000000001466.
4
Correlation of Serum Bilirubin with Clinical and Pathological Characteristics of Patients with IgA Nephropathy.
Arch Esp Urol. 2024 Jun;77(5):531-539. doi: 10.56434/j.arch.esp.urol.20247705.73.
5
Lower Serum Indirect Bilirubin Levels are Inversely Related to Carotid Intima-Media Thickness Progression.
Curr Neurovasc Res. 2019;16(2):148-155. doi: 10.2174/1567202616666190412153735.
6
Relationship between serum bilirubin levels and mortality in patients on peritoneal dialysis.
Ren Fail. 2019 Nov;41(1):532-539. doi: 10.1080/0886022X.2019.1628062.
7
[Association of low serum indirect bilirubin level with all-cause mortality in maintenance hemodialysis patients].
Zhonghua Yi Xue Za Zhi. 2019 Jul 23;99(28):2203-2207. doi: 10.3760/cma.j.issn.0376-2491.2019.28.010.
8
Low serum bilirubin level predicts the development of chronic kidney disease in patients with type 2 diabetes mellitus.
Korean J Intern Med. 2017 Sep;32(5):875-882. doi: 10.3904/kjim.2015.153. Epub 2017 May 31.
9
Total bilirubin independently predicts incident metabolic syndrome among community-dwelling women.
Diabetes Metab Syndr. 2019 Mar-Apr;13(2):1329-1334. doi: 10.1016/j.dsx.2019.02.009. Epub 2019 Feb 5.
10
Association between serum bilirubin and asymptomatic intracranial atherosclerosis: results from a population-based study.
Neurol Sci. 2020 Jun;41(6):1531-1538. doi: 10.1007/s10072-020-04268-x. Epub 2020 Jan 23.

引用本文的文献

1
Relationship between serum total bilirubin and frailty in middle-aged and elderly individuals.
Front Med (Lausanne). 2025 Jul 8;12:1567050. doi: 10.3389/fmed.2025.1567050. eCollection 2025.
2
Bilirubin metabolism in relation to cancer.
Front Oncol. 2025 Apr 11;15:1570288. doi: 10.3389/fonc.2025.1570288. eCollection 2025.
3
2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.
Circulation. 2025 Feb 25;151(8):e41-e660. doi: 10.1161/CIR.0000000000001303. Epub 2025 Jan 27.
6
2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.
Circulation. 2024 Feb 20;149(8):e347-e913. doi: 10.1161/CIR.0000000000001209. Epub 2024 Jan 24.
8
Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association.
Circulation. 2023 Feb 21;147(8):e93-e621. doi: 10.1161/CIR.0000000000001123. Epub 2023 Jan 25.
9
Association of Serum Bilirubin With Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
Front Endocrinol (Lausanne). 2022 Jul 20;13:869579. doi: 10.3389/fendo.2022.869579. eCollection 2022.
10
Bilirubin as an indicator of cardiometabolic health: a cross-sectional analysis in the UK Biobank.
Cardiovasc Diabetol. 2022 Apr 18;21(1):54. doi: 10.1186/s12933-022-01484-x.

本文引用的文献

1
Bilirubin reduces visceral obesity and insulin resistance by suppression of inflammatory cytokines.
PLoS One. 2019 Oct 2;14(10):e0223302. doi: 10.1371/journal.pone.0223302. eCollection 2019.
2
Total bilirubin independently predicts incident metabolic syndrome among community-dwelling women.
Diabetes Metab Syndr. 2019 Mar-Apr;13(2):1329-1334. doi: 10.1016/j.dsx.2019.02.009. Epub 2019 Feb 5.
3
Biomarkers of Oxidative Stress in Metabolic Syndrome and Associated Diseases.
Oxid Med Cell Longev. 2019 May 5;2019:8267234. doi: 10.1155/2019/8267234. eCollection 2019.
4
The Relationship between Serum Bilirubin and Inflammatory Bowel Disease.
Mediators Inflamm. 2019 Apr 15;2019:5256460. doi: 10.1155/2019/5256460. eCollection 2019.
5
Potential impact of the joint association of total bilirubin and gamma-glutamyltransferase with metabolic syndrome.
Diabetol Metab Syndr. 2019 Feb 4;11:12. doi: 10.1186/s13098-019-0408-z. eCollection 2019.
7
Bilirubin, a new therapeutic for kidney transplant?
Transplant Rev (Orlando). 2018 Oct;32(4):234-240. doi: 10.1016/j.trre.2018.06.003. Epub 2018 Jun 28.
8
Direct Bilirubin Levels and Risk of Metabolic Syndrome in Healthy Chinese Men.
Biomed Res Int. 2017;2017:9621615. doi: 10.1155/2017/9621615. Epub 2017 Dec 20.
9
The relationship of alanine aminotransferase to metabolic syndrome in a Korean population.
Turk J Gastroenterol. 2018 Jan;29(1):52-60. doi: 10.5152/tjg.2018.17333.
10
Pathophysiology of the metabolic syndrome.
Clin Dermatol. 2018 Jan-Feb;36(1):14-20. doi: 10.1016/j.clindermatol.2017.09.004. Epub 2017 Sep 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验